000 | 01954 a2200553 4500 | ||
---|---|---|---|
005 | 20250513140531.0 | ||
264 | 0 | _c19980409 | |
008 | 199804s 0 0 eng d | ||
022 | _a0031-1480 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLevine, M M | |
245 | 0 | 0 |
_aA review of the current status of enteric vaccines. _h[electronic resource] |
260 |
_bPapua and New Guinea medical journal _cDec 1995 |
||
300 |
_a325-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdjuvants, Immunologic |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBacterial Typing Techniques |
650 | 0 | 4 | _aBacterial Vaccines |
650 | 0 | 4 | _aCarrier Proteins |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCholera _xprevention & control |
650 | 0 | 4 |
_aCholera Toxin _xadministration & dosage |
650 | 0 | 4 |
_aCholera Vaccines _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDeveloping Countries |
650 | 0 | 4 |
_aDysentery, Bacillary _xprevention & control |
650 | 0 | 4 |
_aEnterobacteriaceae _ximmunology |
650 | 0 | 4 |
_aEnterobacteriaceae Infections _xprevention & control |
650 | 0 | 4 |
_aEscherichia coli _ximmunology |
650 | 0 | 4 |
_aEscherichia coli Infections _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPolysaccharides, Bacterial _ximmunology |
650 | 0 | 4 |
_aRotavirus _ximmunology |
650 | 0 | 4 |
_aRotavirus Infections _xprevention & control |
650 | 0 | 4 |
_aSalmonella typhi _ximmunology |
650 | 0 | 4 |
_aShigella _ximmunology |
650 | 0 | 4 |
_aTyphoid Fever _xprevention & control |
650 | 0 | 4 |
_aTyphoid-Paratyphoid Vaccines _xclassification |
650 | 0 | 4 | _aVaccines, Attenuated |
650 | 0 | 4 | _aVaccines, Conjugate |
650 | 0 | 4 | _aVaccines, Inactivated |
650 | 0 | 4 | _aVaccines, Synthetic |
650 | 0 | 4 |
_aVibrio cholerae _xclassification |
650 | 0 | 4 | _aViral Vaccines |
700 | 1 | _aNoriega, F | |
773 | 0 |
_tPapua and New Guinea medical journal _gvol. 38 _gno. 4 _gp. 325-31 |
|
999 |
_c9490559 _d9490559 |